HLS Therapeutics Inc. (OTCMKTS:HLTRF) Short Interest Update

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 100 shares, a decrease of 96.9% from the March 15th total of 3,200 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is presently 0.1 days.

HLS Therapeutics Stock Performance

Shares of HLTRF opened at $2.96 on Wednesday. HLS Therapeutics has a 52-week low of $2.22 and a 52-week high of $3.56. The firm has a 50-day moving average price of $2.99 and a 200 day moving average price of $2.75.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.